Research indicates that nimatrelvir/ritonavir is ineffective in lowering the majority of post-COVID-19 conditions.

Published Date: 01 Nov 2023

The use of the antiviral nirmatrelvir?ritonavir was found to be ineffective in lowering the risk for numerous post-COVID-19 conditions, including cardiac, pulmonary, and renal problems, according to a trial emulation study of veterans with COVID-19.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

4.

The pandemic had little impact on mental health symptoms.

5.

Men over 75 years old may be significantly more likely to commit suicide if they have cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot